Important Patient Safety Information: Coronavirus (COVID-19)

View Menu

Dr. Campbell Discusses New Glaucoma Medications

For a long time, ophthalmologists had sort of given up on recovering the drainage functions of the trabecular meshwork of a glaucoma patient's eye.

In the past 18 months, the FDA has approved two new glaucoma eyedrop medications and two types of minimally invasive glaucoma surgeries (MIGS) to restore some functionality of the meshwork, said Anita Campbell, MD, a fellowship-trained glaucoma specialist at Grene Vision Group. She has clinics in Wichita and Hutchinson.

Dr. Campbell has started prescribing both new medications – Vyzulta and Rhopressa – and performing both new MIGS procedures – called the Kahook Dual Blade and the OMNI system – to help reduce intraocular pressure (IOP) in the eyes of her glaucoma patients.

Read the article in the February-March 2019 issue of MD News of Greater Kansas magazine by clicking here.

Anita Campbell, MD

Previous: March is National Save Your Vision Month Next: GVG the V1P Sponsor for JDRF OneWalk April 13